Radyolojik görüntülemede karaciğer sağ lob segment 5'de hepatosellüler karsinom (HCC) ile uyumlu kitle lezyonu saptanan ve alfa-fetoprotein yüksekliği (323 ng/mL) olan 43 yaşında erkek bir hasta kliniğimize başvurdu. 
F-FDG uptake levels as the liver parenchyma (E arrowhead, F arrowhead, G). PET/CT did not reveal any other focus that was suspicious for malignancy. Hepatocellular carcinoma (HCC) and cholangiocellular carcinoma (CCC) are both primary malignant liver tumors originating from the hepatocyes and bile duct cells, respectively. The incidence of HCC and CCC together is extremely rare (lower than 1% of all primary malignant liver tumors) (1). Synchronous HCC and CCC cases, some of them on the same segment, detected with CT or magnetic resonance imaging (MRI) studies have previously been reported (2,3). Besides, both HCC and CCC components present in the same tumor and hepatic stem cells differentiating to hepatocytes or cholangio cells have also been reported (3). To our knowledge, this is the first case to report synchronous primary malignant liver tumors in two distinct segments detected by F-FDG uptake in malignant tumors is related to glucose transporter proteins (especially Glut1) and hexokinase type 2. Glut1 expression is low in HCC and high in CCC, while hexokinase 2 expression is elevated in HCC (4).
18
F-FDG uptake is variable in HCC related to the degree of differentiation. Because glucose-6-phosphatase activity is high in well differentiated hepatocyte cells, intracellular F-FDG uptake patterns of both tumors were quite different, so we considered two separate HCC lesions with two distinct degree of differentiation. Histopathologically, the mass lesion with low 18 F-FDG uptake at the right liver lobe segment 5 was reported as clear cell HCC with micro-macro trabecular pattern, nuclear grade 2-3, while the tumor with higher 18 F-FDG uptake at the left liver lobe segment 2 was identified as adenocarcinoma (CCC). The CCC was intrahepatic and therefore the 18 F-FDG uptake was significantly higher.
